A Functional Near- Infrared Spectroscopy Study on the Brain Activation Characteristics of Stroke Patients During Mirror Movement

After the selected patients are determined, the researchers of this study need to have full communication with the patients. The location is the rehabilitation ward of our hospital and the time is

Before joining the group. During this process, the patient should be informed of the purpose, procedures and processes of the trial. The informed consent form should be signed by the patient himself/herself. Such as the patient

Illiterate, the informed consent process was witnessed by an independent witness and signed. The subject pressed their fingerprint at the signature. In the study process fully

Listen to and respond to the questions and opinions of the subjects or their representatives.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

25

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Hangzhou, China
        • Recruiting
        • The Second Affiliated Hospital of Zhejiang University School of Medicine
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The main population of this study consists of individuals aged between 30 and 80 years old who have experienced a stroke for the first time and have residual upper limb dysfunction. There is no limit to the age range.

Description

Inclusion Criteria:

  • It meets the diagnostic criteria of the "Guidelines for the Prevention and Treatment of Cerebrovascular Diseases in China", and is diagnosed as cerebral infarction or cerebral hemorrhage by CT or MRI.
  • The first stroke occurred;
  • The muscle strength of the flexor and extensor muscles of the affected finger is ≤ grade 1.
  • Right-handed player
  • Muscle tone improvement: Asworth level 2 or below;
  • The disease course is within 6 months and the condition is stable.
  • Age: 18 to 75 years old, with normal vision and hearing or corrected to normal.

Exclusion Criteria:

  • Those with an MMSE score less than 20, severe memory, communication and speech command comprehension disorders, and those who cannot cooperate with examinations and treatments;
  • Those with a history of epilepsy;
  • Those with a history of stroke, traumatic brain injury or brain tumor in the past;
  • Those with peripheral nervous system injuries other than stroke as diagnosed by imaging;
  • Those with visual spatial impairments such as visual field defects and unilateral neglect;
  • Skull defect or metal bone plates
  • For those who are not suitable for functional near-infrared examination;
  • Those with a history of intracranial surgery.
  • Patients with lesion areas in the cerebellum or brainstem.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
normal hand movement
Patient will be asked to quickly open and grasp the healthy hand, and keep their eyes on the affected hand.
mirror hand movement
Patients will be asked to place the affected hand in the mirror box. While quickly opening and closing the healthy hand, they should observe the reflection of the healthy hand in the mirror and imagine the affected hand doing the same movements.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
fNIRS measured brain activation
Time Frame: The measurement of the primary outcome indicators occurred after the patients had received one week of hand function rehabilitation training.
The measurement of the primary outcome indicators occurred after the patients had received one week of hand function rehabilitation training.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2024

Primary Completion (Estimated)

May 1, 2030

Study Completion (Estimated)

October 1, 2030

Study Registration Dates

First Submitted

May 6, 2025

First Submitted That Met QC Criteria

March 29, 2026

First Posted (Actual)

April 3, 2026

Study Record Updates

Last Update Posted (Actual)

April 3, 2026

Last Update Submitted That Met QC Criteria

March 29, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on healthy hand movement

Subscribe